Opioid Addiction
- All
- News
- Videos
-
India Bans Two Addictive Opioids Amid Misuse In West Africa
The drugs were being illegally exported to West African countries by Mumbai-based Aveo Pharmaceuticals
-
FDA Approves Suzetrigine, First Non-Opioid Painkiller in Decades
The FDA has approved suzetrigine, a groundbreaking painkiller that blocks sodium channels to provide opioid-level pain relief without the risks of addiction, sedation, or overdose. Known as Journavx, this drug is the first in over two decades to introduce a new pain relief mechanism. Clinical trials showed it matched opioids in effectiveness but wi...
-
Failure of AstraZeneca Trial Big Blow For Anti-Addiction Drugs: Report
The failure of the trial of the drug AZD4041 by pharma giant AstraZeneca, to combat opioid use disorder (OUD), highlights the challenges in developing non-opioid medications that treat addiction and withdrawal, according to a report.
-
Placebo Effect Link Discovered With Previously Unassociated Parts of the Brain
Patients suffering from chronic pain have limited treatment options, often relying on medications like opioids that come with harmful side effects and high addiction risks. A new study in mice, published in Current Biology journal, suggests a new way to use the placebo effect for treating chronic pain. By activating specific neurons in the brain li...
-
Indian-American Gitanjali Rao, 15, First-Ever TIME "Kid Of The Year"
15-year-old Indian-American Gitanjali Rao, a "brilliant" young scientist and inventor, has been named by TIME magazine as the first-ever 'Kid of the Year' for her "astonishing work" using technology to tackle issues ranging from contaminated drinking water to opioid addiction and cyberbullying.
-
Indian-Origin Doctor Faces 20 Years In Jail For Writing Illegal Medicines
An Indian-origin doctor pleaded guilty to illegally giving controlled substances to six patients, including one who suffered from opioid addiction and later died of a drug overdose.Gurpreet Singh Bajwa, 49 of Fairfax, Virginia temporarily lost his medical license in 2012 following an investigation by the Virginia Department of Health Professions (D...
-
Johnson & Johnson Reaches $20.4 Million Settlement Ahead Of Opioid Trial
US healthcare giant Johnson & Johnson on Tuesday announced it had reached a $20.4 million settlement to avoid a much-anticipated trial in Ohio for allegedly fueling the opioid addiction crisis.
-
Johnson & Johnson Verdict Sends Opioid Makers A Billion-Dollar Warning
The US pharmaceutical industry faces tens of billions of dollars in potential damage payments for fueling the opioid addiction crisis after Oklahoma won a $572 million judgment against drugmaker Johnson & Johnson.
-
Johnson & Johnson Ordered To Pay $572 Million For Opioid Addiction Crisis
An Oklahoma judge on Monday ordered US health care giant Johnson & Johnson to pay $572 million in damages for its role in fostering the state's opioid addiction crisis.
-
Johnson & Johnson Faces Possible $17 Billion Payout For Pushing Opiods
US drugmaker Johnson & Johnson faces a potential record $17 billion damages payout Monday when an Oklahoma judge rules whether its aggressive promotion of opioid painkillers was responsible for the state's addiction epidemic.
-
Indian-Origin Drug Firm Founder, Executives Convicted In US Opioid Case
A 76-year-old Indian-origin head of a US pharmaceutical major has become the first top executive of a drugmaker to be convicted of bribing doctors in America to prescribe addictive painkillers, fuelling a national opioid crisis which has claimed the lives of tens of thousands of people over two decades.
-
US Doctors, Pharmacists Charged In Crackdown On Opioid Prescriptions
The US Justice Department announced charges Wednesday against 60 people, including doctors, nurses and pharmacists alleged to have illegally written hundreds of thousands of prescriptions for opioids that have underpinned the country's addiction crisis.
-
India-Born Billionaire Bribed Doctors With Cash, Strip Clubs, On Trial
The first prosecution of a pharmaceutical company chief executive tied to opioid overdoses begins this week, when Insys Therapeutics Inc.'s John Kapoor goes on trial. The fallout may jolt an industry facing steep penalties for its own role in the crisis.
-
Study: Dental Painkillers May Put Young People At Risk Of Opioid Addiction
Adolescents and young adults often are introduced to highly addictive opioid painkillers when they have their third molars pulled.
-
FDA Approves A Powerful New Opioid Amid Warnings Of Likely Abuse
This tiny pill just three millimeters in diameter is likely to worsen the nation's drug crisis, according to critics and the head of the FDA's advisory committee on painkillers.
-
India Bans Two Addictive Opioids Amid Misuse In West Africa
The drugs were being illegally exported to West African countries by Mumbai-based Aveo Pharmaceuticals
-
FDA Approves Suzetrigine, First Non-Opioid Painkiller in Decades
The FDA has approved suzetrigine, a groundbreaking painkiller that blocks sodium channels to provide opioid-level pain relief without the risks of addiction, sedation, or overdose. Known as Journavx, this drug is the first in over two decades to introduce a new pain relief mechanism. Clinical trials showed it matched opioids in effectiveness but wi...
-
Failure of AstraZeneca Trial Big Blow For Anti-Addiction Drugs: Report
The failure of the trial of the drug AZD4041 by pharma giant AstraZeneca, to combat opioid use disorder (OUD), highlights the challenges in developing non-opioid medications that treat addiction and withdrawal, according to a report.
-
Placebo Effect Link Discovered With Previously Unassociated Parts of the Brain
Patients suffering from chronic pain have limited treatment options, often relying on medications like opioids that come with harmful side effects and high addiction risks. A new study in mice, published in Current Biology journal, suggests a new way to use the placebo effect for treating chronic pain. By activating specific neurons in the brain li...
-
Indian-American Gitanjali Rao, 15, First-Ever TIME "Kid Of The Year"
15-year-old Indian-American Gitanjali Rao, a "brilliant" young scientist and inventor, has been named by TIME magazine as the first-ever 'Kid of the Year' for her "astonishing work" using technology to tackle issues ranging from contaminated drinking water to opioid addiction and cyberbullying.
-
Indian-Origin Doctor Faces 20 Years In Jail For Writing Illegal Medicines
An Indian-origin doctor pleaded guilty to illegally giving controlled substances to six patients, including one who suffered from opioid addiction and later died of a drug overdose.Gurpreet Singh Bajwa, 49 of Fairfax, Virginia temporarily lost his medical license in 2012 following an investigation by the Virginia Department of Health Professions (D...
-
Johnson & Johnson Reaches $20.4 Million Settlement Ahead Of Opioid Trial
US healthcare giant Johnson & Johnson on Tuesday announced it had reached a $20.4 million settlement to avoid a much-anticipated trial in Ohio for allegedly fueling the opioid addiction crisis.
-
Johnson & Johnson Verdict Sends Opioid Makers A Billion-Dollar Warning
The US pharmaceutical industry faces tens of billions of dollars in potential damage payments for fueling the opioid addiction crisis after Oklahoma won a $572 million judgment against drugmaker Johnson & Johnson.
-
Johnson & Johnson Ordered To Pay $572 Million For Opioid Addiction Crisis
An Oklahoma judge on Monday ordered US health care giant Johnson & Johnson to pay $572 million in damages for its role in fostering the state's opioid addiction crisis.
-
Johnson & Johnson Faces Possible $17 Billion Payout For Pushing Opiods
US drugmaker Johnson & Johnson faces a potential record $17 billion damages payout Monday when an Oklahoma judge rules whether its aggressive promotion of opioid painkillers was responsible for the state's addiction epidemic.
-
Indian-Origin Drug Firm Founder, Executives Convicted In US Opioid Case
A 76-year-old Indian-origin head of a US pharmaceutical major has become the first top executive of a drugmaker to be convicted of bribing doctors in America to prescribe addictive painkillers, fuelling a national opioid crisis which has claimed the lives of tens of thousands of people over two decades.
-
US Doctors, Pharmacists Charged In Crackdown On Opioid Prescriptions
The US Justice Department announced charges Wednesday against 60 people, including doctors, nurses and pharmacists alleged to have illegally written hundreds of thousands of prescriptions for opioids that have underpinned the country's addiction crisis.
-
India-Born Billionaire Bribed Doctors With Cash, Strip Clubs, On Trial
The first prosecution of a pharmaceutical company chief executive tied to opioid overdoses begins this week, when Insys Therapeutics Inc.'s John Kapoor goes on trial. The fallout may jolt an industry facing steep penalties for its own role in the crisis.
-
Study: Dental Painkillers May Put Young People At Risk Of Opioid Addiction
Adolescents and young adults often are introduced to highly addictive opioid painkillers when they have their third molars pulled.
-
FDA Approves A Powerful New Opioid Amid Warnings Of Likely Abuse
This tiny pill just three millimeters in diameter is likely to worsen the nation's drug crisis, according to critics and the head of the FDA's advisory committee on painkillers.
